HITIQ granted new Australian patent for Nexus™ technology

HITIQ Limited (ASX: $HIQ) has been awarded its fourth Australian Patent, further solidifying its position as a global leader in concussion management technologies. The newly granted Patent (No. 2020219864) covers IP related to its Nexus™ instrumented mouthguard head impact technology, enhancing the protection of HITIQ's commercial Intellectual Property (IP) position.

HITIQ Chief Executive, Mike Vegar, on the new Australian Patent

Protecting our IP is an ongoing focus as a part of our commercial strategy that will continue to secure our position as the global leader in concussion management technologies. We have a pipeline of global patent initiatives across our suite of products which the Company will develop and activate as required.

Summary of HITIQ's new Australian Patent and outlook

HITIQ (ASX: $HIQ) has been granted a fourth Australian Patent, further strengthening its IP portfolio related to its Nexus™ instrumented mouthguard head impact technology. The company's focus on protecting its IP underscores its commitment to maintaining a leading position in concussion management technologies. With a pipeline of global patent initiatives, HITIQ aims to continue developing and activating patents as required, solidifying its position in the market and enhancing its concussion management solutions for professional and amateur sports players, clinicians, and progressive leagues worldwide.